Lucentis (Ranibizumab Vials) 10mg/ml 0.23ml/2.3mg

Lucentis (Ranibizumab) 10mg/ml 0.23ml/2.3mg vials are prescribed for eye conditions like wet age-related macular degeneration and diabetic macular edema. This prescription-only treatment helps maintain vision clarity by targeting abnormal blood vessel growth. Store refrigerated between 2-8°C to preserve potency.

Strength

10mg/ml 0.23ml/2.3mg

Pack Size

Storage

2-8ºC

Manufacturer / TM Owner

Novartis Pharma Stein AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lucentis (Ranibizumab) is used to treat eye conditions caused by abnormal blood vessel growth, such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It may also be prescribed for macular edema following retinal vein occlusion. This medication helps reduce fluid leakage and swelling in the retina, supporting vision maintenance. Always follow your healthcare provider’s guidance for use.

Side Effects

Lucentis works by targeting a protein that promotes abnormal blood vessel growth in the eye. This helps reduce swelling and leakage in the retina, which can improve or stabilize vision over time. Patients may notice gradual changes in vision clarity as treatment progresses. Regular monitoring with an eye care professional is recommended.

Precautions & Warnings

Lucentis is a prescription medication and should only be handled by trained healthcare professionals. Store vials refrigerated between 2-8°C and protect from light until use. Do not freeze or shake the vial. Discard any unused portion after use as it is for single-patient administration only. Always inform your doctor of any allergies or ongoing treatments.

Avoid Interactions

Lucentis is administered via injection and has limited systemic exposure, reducing direct drug interactions. However, caution is advised when combining with other intravitreal therapies or blood thinners. Discuss all medications, including over-the-counter drugs and supplements, with your healthcare provider before treatment. Rarely, concurrent use of systemic anti-VEGF agents may increase risks.

Frequently Asked Questions

Lucentis (Ranibizumab) is used to treat eye conditions like wet age-related macular degeneration and diabetic macular edema by reducing abnormal blood vessel growth.

Lucentis is given as an intravitreal injection by a healthcare professional, typically in a clinical setting.

No, Lucentis vials must be refrigerated between 2-8°C and protected from light until use.

Lucentis is a prescription medication; suitability depends on individual health conditions and should be determined by a healthcare provider.

Common effects may include eye redness, discomfort, or temporary vision changes; report any persistent issues to your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.